Click for best price
Liposomal Formulation Development Service Market Size, Share 2024
The global Liposomal Formulation Development Service market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Small Molecules Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Liposomal Formulation Development Service include Creative Biolabs, LipExoGen, Project Pharmaceutics, Polymun, Exelead, CD Formulation, Anglo Bio-Pharma Limited, Liposoma BV and Dalton Pharma Services, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Liposomal Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Formulation Development Service. This report contains market size and forecasts of Liposomal Formulation Development Service in global, including the following market information:
Global Liposomal Formulation Development Service Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Liposomal Formulation Development Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal Formulation Development Service Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Liposomal Formulation Development Service Market Segment Percentages, by Type, 2023 (%)
Small Molecules
Proteins
Peptides
Nucleic Acids
Others
Global Liposomal Formulation Development Service Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Liposomal Formulation Development Service Market Segment Percentages, by Application, 2023 (%)
Research
Clinical
Commercial
Global Liposomal Formulation Development Service Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Liposomal Formulation Development Service Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Formulation Development Service revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Liposomal Formulation Development Service revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Creative Biolabs
LipExoGen
Project Pharmaceutics
Polymun
Exelead
CD Formulation
Anglo Bio-Pharma Limited
Liposoma BV
Dalton Pharma Services
Creative Biostructure
BOC Sciences
Encapsula NanoSciences LLC
Fujifilm
CD Bioparticles
Precision NanoSystems
Evonik
Genevant Sciences
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Corden Pharma
Acuitas Therapeutics
T&T Scientific
FormuMax Scientific
PlantaCorp
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomal Formulation Development Service, market overview.
Chapter 2: Global Liposomal Formulation Development Service market size in revenue.
Chapter 3: Detailed analysis of Liposomal Formulation Development Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomal Formulation Development Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Liposomal Formulation Development Service Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomal Formulation Development Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal Formulation Development Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal Formulation Development Service Overall Market Size
2.1 Global Liposomal Formulation Development Service Market Size: 2023 VS 2030
2.2 Global Liposomal Formulation Development Service Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomal Formulation Development Service Players in Global Market
3.2 Top Global Liposomal Formulation Development Service Companies Ranked by Revenue
3.3 Global Liposomal Formulation Development Service Revenue by Companies
3.4 Top 3 and Top 5 Liposomal Formulation Development Service Companies in Global Market, by Revenue in 2023
3.5 Global Companies Liposomal Formulation Development Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomal Formulation Development Service Players in Global Market
3.6.1 List of Global Tier 1 Liposomal Formulation Development Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomal Formulation Development Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomal Formulation Development Service Market Size Markets, 2023 & 2030
4.1.2 Small Molecules
4.1.3 Proteins
4.1.4 Peptides
4.1.5 Nucleic Acids
4.1.6 Others
4.2 By Type - Global Liposomal Formulation Development Service Revenue & Forecasts
4.2.1 By Type - Global Liposomal Formulation Development Service Revenue, 2019-2024
4.2.2 By Type - Global Liposomal Formulation Development Service Revenue, 2025-2030
4.2.3 By Type - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal Formulation Development Service Market Size, 2023 & 2030
5.1.2 Research
5.1.3 Clinical
5.1.4 Commercial
5.2 By Application - Global Liposomal Formulation Development Service Revenue & Forecasts
5.2.1 By Application - Global Liposomal Formulation Development Service Revenue, 2019-2024
5.2.2 By Application - Global Liposomal Formulation Development Service Revenue, 2025-2030
5.2.3 By Application - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Liposomal Formulation Development Service Market Size, 2023 & 2030
6.2 By Region - Global Liposomal Formulation Development Service Revenue & Forecasts
6.2.1 By Region - Global Liposomal Formulation Development Service Revenue, 2019-2024
6.2.2 By Region - Global Liposomal Formulation Development Service Revenue, 2025-2030
6.2.3 By Region - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Liposomal Formulation Development Service Revenue, 2019-2030
6.3.2 US Liposomal Formulation Development Service Market Size, 2019-2030
6.3.3 Canada Liposomal Formulation Development Service Market Size, 2019-2030
6.3.4 Mexico Liposomal Formulation Development Service Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Liposomal Formulation Development Service Revenue, 2019-2030
6.4.2 Germany Liposomal Formulation Development Service Market Size, 2019-2030
6.4.3 France Liposomal Formulation Development Service Market Size, 2019-2030
6.4.4 U.K. Liposomal Formulation Development Service Market Size, 2019-2030
6.4.5 Italy Liposomal Formulation Development Service Market Size, 2019-2030
6.4.6 Russia Liposomal Formulation Development Service Market Size, 2019-2030
6.4.7 Nordic Countries Liposomal Formulation Development Service Market Size, 2019-2030
6.4.8 Benelux Liposomal Formulation Development Service Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Liposomal Formulation Development Service Revenue, 2019-2030
6.5.2 China Liposomal Formulation Development Service Market Size, 2019-2030
6.5.3 Japan Liposomal Formulation Development Service Market Size, 2019-2030
6.5.4 South Korea Liposomal Formulation Development Service Market Size, 2019-2030
6.5.5 Southeast Asia Liposomal Formulation Development Service Market Size, 2019-2030
6.5.6 India Liposomal Formulation Development Service Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Liposomal Formulation Development Service Revenue, 2019-2030
6.6.2 Brazil Liposomal Formulation Development Service Market Size, 2019-2030
6.6.3 Argentina Liposomal Formulation Development Service Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomal Formulation Development Service Revenue, 2019-2030
6.7.2 Turkey Liposomal Formulation Development Service Market Size, 2019-2030
6.7.3 Israel Liposomal Formulation Development Service Market Size, 2019-2030
6.7.4 Saudi Arabia Liposomal Formulation Development Service Market Size, 2019-2030
6.7.5 UAE Liposomal Formulation Development Service Market Size, 2019-2030
7 Liposomal Formulation Development Service Companies Profiles
7.1 Creative Biolabs
7.1.1 Creative Biolabs Company Summary
7.1.2 Creative Biolabs Business Overview
7.1.3 Creative Biolabs Liposomal Formulation Development Service Major Product Offerings
7.1.4 Creative Biolabs Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.1.5 Creative Biolabs Key News & Latest Developments
7.2 LipExoGen
7.2.1 LipExoGen Company Summary
7.2.2 LipExoGen Business Overview
7.2.3 LipExoGen Liposomal Formulation Development Service Major Product Offerings
7.2.4 LipExoGen Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.2.5 LipExoGen Key News & Latest Developments
7.3 Project Pharmaceutics
7.3.1 Project Pharmaceutics Company Summary
7.3.2 Project Pharmaceutics Business Overview
7.3.3 Project Pharmaceutics Liposomal Formulation Development Service Major Product Offerings
7.3.4 Project Pharmaceutics Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.3.5 Project Pharmaceutics Key News & Latest Developments
7.4 Polymun
7.4.1 Polymun Company Summary
7.4.2 Polymun Business Overview
7.4.3 Polymun Liposomal Formulation Development Service Major Product Offerings
7.4.4 Polymun Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.4.5 Polymun Key News & Latest Developments
7.5 Exelead
7.5.1 Exelead Company Summary
7.5.2 Exelead Business Overview
7.5.3 Exelead Liposomal Formulation Development Service Major Product Offerings
7.5.4 Exelead Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.5.5 Exelead Key News & Latest Developments
7.6 CD Formulation
7.6.1 CD Formulation Company Summary
7.6.2 CD Formulation Business Overview
7.6.3 CD Formulation Liposomal Formulation Development Service Major Product Offerings
7.6.4 CD Formulation Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.6.5 CD Formulation Key News & Latest Developments
7.7 Anglo Bio-Pharma Limited
7.7.1 Anglo Bio-Pharma Limited Company Summary
7.7.2 Anglo Bio-Pharma Limited Business Overview
7.7.3 Anglo Bio-Pharma Limited Liposomal Formulation Development Service Major Product Offerings
7.7.4 Anglo Bio-Pharma Limited Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.7.5 Anglo Bio-Pharma Limited Key News & Latest Developments
7.8 Liposoma BV
7.8.1 Liposoma BV Company Summary
7.8.2 Liposoma BV Business Overview
7.8.3 Liposoma BV Liposomal Formulation Development Service Major Product Offerings
7.8.4 Liposoma BV Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.8.5 Liposoma BV Key News & Latest Developments
7.9 Dalton Pharma Services
7.9.1 Dalton Pharma Services Company Summary
7.9.2 Dalton Pharma Services Business Overview
7.9.3 Dalton Pharma Services Liposomal Formulation Development Service Major Product Offerings
7.9.4 Dalton Pharma Services Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.9.5 Dalton Pharma Services Key News & Latest Developments
7.10 Creative Biostructure
7.10.1 Creative Biostructure Company Summary
7.10.2 Creative Biostructure Business Overview
7.10.3 Creative Biostructure Liposomal Formulation Development Service Major Product Offerings
7.10.4 Creative Biostructure Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.10.5 Creative Biostructure Key News & Latest Developments
7.11 BOC Sciences
7.11.1 BOC Sciences Company Summary
7.11.2 BOC Sciences Business Overview
7.11.3 BOC Sciences Liposomal Formulation Development Service Major Product Offerings
7.11.4 BOC Sciences Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.11.5 BOC Sciences Key News & Latest Developments
7.12 Encapsula NanoSciences LLC
7.12.1 Encapsula NanoSciences LLC Company Summary
7.12.2 Encapsula NanoSciences LLC Business Overview
7.12.3 Encapsula NanoSciences LLC Liposomal Formulation Development Service Major Product Offerings
7.12.4 Encapsula NanoSciences LLC Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.12.5 Encapsula NanoSciences LLC Key News & Latest Developments
7.13 Fujifilm
7.13.1 Fujifilm Company Summary
7.13.2 Fujifilm Business Overview
7.13.3 Fujifilm Liposomal Formulation Development Service Major Product Offerings
7.13.4 Fujifilm Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.13.5 Fujifilm Key News & Latest Developments
7.14 CD Bioparticles
7.14.1 CD Bioparticles Company Summary
7.14.2 CD Bioparticles Business Overview
7.14.3 CD Bioparticles Liposomal Formulation Development Service Major Product Offerings
7.14.4 CD Bioparticles Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.14.5 CD Bioparticles Key News & Latest Developments
7.15 Precision NanoSystems
7.15.1 Precision NanoSystems Company Summary
7.15.2 Precision NanoSystems Business Overview
7.15.3 Precision NanoSystems Liposomal Formulation Development Service Major Product Offerings
7.15.4 Precision NanoSystems Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.15.5 Precision NanoSystems Key News & Latest Developments
7.16 Evonik
7.16.1 Evonik Company Summary
7.16.2 Evonik Business Overview
7.16.3 Evonik Liposomal Formulation Development Service Major Product Offerings
7.16.4 Evonik Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.16.5 Evonik Key News & Latest Developments
7.17 Genevant Sciences
7.17.1 Genevant Sciences Company Summary
7.17.2 Genevant Sciences Business Overview
7.17.3 Genevant Sciences Liposomal Formulation Development Service Major Product Offerings
7.17.4 Genevant Sciences Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.17.5 Genevant Sciences Key News & Latest Developments
7.18 Avanti Polar Lipids
7.18.1 Avanti Polar Lipids Company Summary
7.18.2 Avanti Polar Lipids Business Overview
7.18.3 Avanti Polar Lipids Liposomal Formulation Development Service Major Product Offerings
7.18.4 Avanti Polar Lipids Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.18.5 Avanti Polar Lipids Key News & Latest Developments
7.19 Nippon Fine Chemical
7.19.1 Nippon Fine Chemical Company Summary
7.19.2 Nippon Fine Chemical Business Overview
7.19.3 Nippon Fine Chemical Liposomal Formulation Development Service Major Product Offerings
7.19.4 Nippon Fine Chemical Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.19.5 Nippon Fine Chemical Key News & Latest Developments
7.20 Lipoid
7.20.1 Lipoid Company Summary
7.20.2 Lipoid Business Overview
7.20.3 Lipoid Liposomal Formulation Development Service Major Product Offerings
7.20.4 Lipoid Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.20.5 Lipoid Key News & Latest Developments
7.21 Corden Pharma
7.21.1 Corden Pharma Company Summary
7.21.2 Corden Pharma Business Overview
7.21.3 Corden Pharma Liposomal Formulation Development Service Major Product Offerings
7.21.4 Corden Pharma Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.21.5 Corden Pharma Key News & Latest Developments
7.22 Acuitas Therapeutics
7.22.1 Acuitas Therapeutics Company Summary
7.22.2 Acuitas Therapeutics Business Overview
7.22.3 Acuitas Therapeutics Liposomal Formulation Development Service Major Product Offerings
7.22.4 Acuitas Therapeutics Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.22.5 Acuitas Therapeutics Key News & Latest Developments
7.23 T&T Scientific
7.23.1 T&T Scientific Company Summary
7.23.2 T&T Scientific Business Overview
7.23.3 T&T Scientific Liposomal Formulation Development Service Major Product Offerings
7.23.4 T&T Scientific Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.23.5 T&T Scientific Key News & Latest Developments
7.24 FormuMax Scientific
7.24.1 FormuMax Scientific Company Summary
7.24.2 FormuMax Scientific Business Overview
7.24.3 FormuMax Scientific Liposomal Formulation Development Service Major Product Offerings
7.24.4 FormuMax Scientific Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.24.5 FormuMax Scientific Key News & Latest Developments
7.25 PlantaCorp
7.25.1 PlantaCorp Company Summary
7.25.2 PlantaCorp Business Overview
7.25.3 PlantaCorp Liposomal Formulation Development Service Major Product Offerings
7.25.4 PlantaCorp Liposomal Formulation Development Service Revenue in Global Market (2019-2024)
7.25.5 PlantaCorp Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Liposomal Formulation Development Service Market Opportunities & Trends in Global Market
Table 2. Liposomal Formulation Development Service Market Drivers in Global Market
Table 3. Liposomal Formulation Development Service Market Restraints in Global Market
Table 4. Key Players of Liposomal Formulation Development Service in Global Market
Table 5. Top Liposomal Formulation Development Service Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Liposomal Formulation Development Service Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Liposomal Formulation Development Service Revenue Share by Companies, 2019-2024
Table 8. Global Companies Liposomal Formulation Development Service Product Type
Table 9. List of Global Tier 1 Liposomal Formulation Development Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Formulation Development Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Liposomal Formulation Development Service Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Liposomal Formulation Development Service Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Liposomal Formulation Development Service Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Liposomal Formulation Development Service Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Liposomal Formulation Development Service Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Liposomal Formulation Development Service Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Liposomal Formulation Development Service Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Liposomal Formulation Development Service Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Liposomal Formulation Development Service Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Liposomal Formulation Development Service Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Liposomal Formulation Development Service Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Liposomal Formulation Development Service Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Liposomal Formulation Development Service Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Liposomal Formulation Development Service Revenue, (US$, Mn), 2025-2030
Table 30. Creative Biolabs Company Summary
Table 31. Creative Biolabs Liposomal Formulation Development Service Product Offerings
Table 32. Creative Biolabs Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 33. Creative Biolabs Key News & Latest Developments
Table 34. LipExoGen Company Summary
Table 35. LipExoGen Liposomal Formulation Development Service Product Offerings
Table 36. LipExoGen Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 37. LipExoGen Key News & Latest Developments
Table 38. Project Pharmaceutics Company Summary
Table 39. Project Pharmaceutics Liposomal Formulation Development Service Product Offerings
Table 40. Project Pharmaceutics Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 41. Project Pharmaceutics Key News & Latest Developments
Table 42. Polymun Company Summary
Table 43. Polymun Liposomal Formulation Development Service Product Offerings
Table 44. Polymun Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 45. Polymun Key News & Latest Developments
Table 46. Exelead Company Summary
Table 47. Exelead Liposomal Formulation Development Service Product Offerings
Table 48. Exelead Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 49. Exelead Key News & Latest Developments
Table 50. CD Formulation Company Summary
Table 51. CD Formulation Liposomal Formulation Development Service Product Offerings
Table 52. CD Formulation Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 53. CD Formulation Key News & Latest Developments
Table 54. Anglo Bio-Pharma Limited Company Summary
Table 55. Anglo Bio-Pharma Limited Liposomal Formulation Development Service Product Offerings
Table 56. Anglo Bio-Pharma Limited Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 57. Anglo Bio-Pharma Limited Key News & Latest Developments
Table 58. Liposoma BV Company Summary
Table 59. Liposoma BV Liposomal Formulation Development Service Product Offerings
Table 60. Liposoma BV Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 61. Liposoma BV Key News & Latest Developments
Table 62. Dalton Pharma Services Company Summary
Table 63. Dalton Pharma Services Liposomal Formulation Development Service Product Offerings
Table 64. Dalton Pharma Services Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 65. Dalton Pharma Services Key News & Latest Developments
Table 66. Creative Biostructure Company Summary
Table 67. Creative Biostructure Liposomal Formulation Development Service Product Offerings
Table 68. Creative Biostructure Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 69. Creative Biostructure Key News & Latest Developments
Table 70. BOC Sciences Company Summary
Table 71. BOC Sciences Liposomal Formulation Development Service Product Offerings
Table 72. BOC Sciences Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 73. BOC Sciences Key News & Latest Developments
Table 74. Encapsula NanoSciences LLC Company Summary
Table 75. Encapsula NanoSciences LLC Liposomal Formulation Development Service Product Offerings
Table 76. Encapsula NanoSciences LLC Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 77. Encapsula NanoSciences LLC Key News & Latest Developments
Table 78. Fujifilm Company Summary
Table 79. Fujifilm Liposomal Formulation Development Service Product Offerings
Table 80. Fujifilm Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 81. Fujifilm Key News & Latest Developments
Table 82. CD Bioparticles Company Summary
Table 83. CD Bioparticles Liposomal Formulation Development Service Product Offerings
Table 84. CD Bioparticles Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 85. CD Bioparticles Key News & Latest Developments
Table 86. Precision NanoSystems Company Summary
Table 87. Precision NanoSystems Liposomal Formulation Development Service Product Offerings
Table 88. Precision NanoSystems Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 89. Precision NanoSystems Key News & Latest Developments
Table 90. Evonik Company Summary
Table 91. Evonik Liposomal Formulation Development Service Product Offerings
Table 92. Evonik Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 93. Evonik Key News & Latest Developments
Table 94. Genevant Sciences Company Summary
Table 95. Genevant Sciences Liposomal Formulation Development Service Product Offerings
Table 96. Genevant Sciences Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 97. Genevant Sciences Key News & Latest Developments
Table 98. Avanti Polar Lipids Company Summary
Table 99. Avanti Polar Lipids Liposomal Formulation Development Service Product Offerings
Table 100. Avanti Polar Lipids Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 101. Avanti Polar Lipids Key News & Latest Developments
Table 102. Nippon Fine Chemical Company Summary
Table 103. Nippon Fine Chemical Liposomal Formulation Development Service Product Offerings
Table 104. Nippon Fine Chemical Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 105. Nippon Fine Chemical Key News & Latest Developments
Table 106. Lipoid Company Summary
Table 107. Lipoid Liposomal Formulation Development Service Product Offerings
Table 108. Lipoid Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 109. Lipoid Key News & Latest Developments
Table 110. Corden Pharma Company Summary
Table 111. Corden Pharma Liposomal Formulation Development Service Product Offerings
Table 112. Corden Pharma Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 113. Corden Pharma Key News & Latest Developments
Table 114. Acuitas Therapeutics Company Summary
Table 115. Acuitas Therapeutics Liposomal Formulation Development Service Product Offerings
Table 116. Acuitas Therapeutics Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 117. Acuitas Therapeutics Key News & Latest Developments
Table 118. T&T Scientific Company Summary
Table 119. T&T Scientific Liposomal Formulation Development Service Product Offerings
Table 120. T&T Scientific Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 121. T&T Scientific Key News & Latest Developments
Table 122. FormuMax Scientific Company Summary
Table 123. FormuMax Scientific Liposomal Formulation Development Service Product Offerings
Table 124. FormuMax Scientific Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 125. FormuMax Scientific Key News & Latest Developments
Table 126. PlantaCorp Company Summary
Table 127. PlantaCorp Liposomal Formulation Development Service Product Offerings
Table 128. PlantaCorp Liposomal Formulation Development Service Revenue (US$, Mn) & (2019-2024)
Table 129. PlantaCorp Key News & Latest Developments
List of Figures
Figure 1. Liposomal Formulation Development Service Segment by Type in 2023
Figure 2. Liposomal Formulation Development Service Segment by Application in 2023
Figure 3. Global Liposomal Formulation Development Service Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Liposomal Formulation Development Service Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Liposomal Formulation Development Service Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposomal Formulation Development Service Revenue in 2023
Figure 8. By Type - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 9. By Application - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 10. By Type - Global Liposomal Formulation Development Service Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 12. By Application - Global Liposomal Formulation Development Service Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 14. By Region - Global Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 15. By Country - North America Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 16. US Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 20. Germany Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 21. France Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 28. China Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 32. India Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 34. Brazil Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Liposomal Formulation Development Service Revenue Market Share, 2019-2030
Figure 37. Turkey Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Liposomal Formulation Development Service Revenue, (US$, Mn), 2019-2030
Figure 41. Creative Biolabs Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. LipExoGen Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Project Pharmaceutics Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Polymun Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Exelead Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. CD Formulation Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Anglo Bio-Pharma Limited Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Liposoma BV Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Dalton Pharma Services Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Creative Biostructure Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. BOC Sciences Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Encapsula NanoSciences LLC Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Fujifilm Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. CD Bioparticles Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Precision NanoSystems Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Evonik Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Genevant Sciences Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Avanti Polar Lipids Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Nippon Fine Chemical Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. Lipoid Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 61. Corden Pharma Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 62. Acuitas Therapeutics Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 63. T&T Scientific Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 64. FormuMax Scientific Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 65. PlantaCorp Liposomal Formulation Development Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
